SCHEMBL30938988

SCHEMBL30938988

COC(=O)c1cc(Br)cc(OCC(=O)OC(C)(C)C)c1CBr

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.36
▸ HPGD P15428 3/20 0.36
▸ POLB P06746 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ CYP2C19 P33261 2/20 0.35
▸ MAPT P10636 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ MTNR1A P48039 3/20 0.35
▸ MTNR1B P49286 3/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ CYP1A2 P05177 2/20 0.33
▸ PTGDR2 Q9Y5Y4 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ PSEN1 P49768 1/20 0.32
▸ PSEN2 P49810 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24744883 0.87 MTNR1A (0.34) ALDH1A1HPGDPOLBKDM4EHSD17B10
SCHEMBL31443911 0.85 ALDH1A1 (0.39) ALDH1A1HPGDPOLBKDM4EHSD17B10
SCHEMBL31426305 0.81 PTGDR2 (0.50) ALDH1A1HPGDPOLBHSD17B10CYP2C19
SCHEMBL23704924 0.79 KDM4E (0.44) ALDH1A1HPGDPOLBKDM4EHSD17B10
SCHEMBL38663430 0.79 KDM4E (0.44) ALDH1A1HPGDPOLBKDM4EHSD17B10
SCHEMBL18703867 0.76 ALDH1A1 (0.43) ALDH1A1HPGDPOLBKDM4EHSD17B10
SCHEMBL29090416 0.75 ATR (0.41) ALDH1A1KDM4ESMN1; SMN2ATRNOTUM
SCHEMBL31444016 0.75 CFD (0.43) ALDH1A1HPGDPOLBKDM4EHSD17B10
SCHEMBL24745569 0.75 MTNR1A (0.42) ALDH1A1HPGDPOLBKDM4EHSD17B10
SCHEMBL22823053 0.74 HPGD (0.39) ALDH1A1HPGDPOLBKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630414-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN Captor Therapeutics S.A. (PL) 2025-10-15 — — EP disclosed
WO-2025096856-A1 COVALENT CEREBLON LIGANDS C4 THERAPEUTICS, INC. (US) 2025-05-08 — — WO disclosed
WO-2024121256-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2024-06-13 — — WO disclosed
Send feedback